Reported 2 days ago
Morgan Stanley has initiated coverage on Centene Corporation (CNC) with an Overweight rating and a target price of $70, citing optimism about the company's Medicaid growth and dual-eligible integration potential. Despite potential policy challenges, analyst Ricky Goldwasser believes the risks are manageable. In Q1 2025, Centene's revenue was $46.62 billion, a 15.4% increase from the previous year, even as the number of customers slightly decreased. CEO Sarah London noted that improvements in Medicaid rates and new contracts have positively affected performance.
Source: YAHOO